Aehr Test Systems (AEHR) EBITDA (2010 - 2026)

Aehr Test Systems (AEHR) has reported EBITDA for 17 consecutive years, with -$1.2 million the latest figure, recorded in Q2 2026.

• EBITDA for Q2 2026 came in at -$1.2 million, up 62.36% year-over-year; the trailing twelve-month figure through May 2026 was -$14.1 million (down 149.23% YoY), and the FY2026 annual result was -$14.1 million, down 149.23% from the prior year.
• EBITDA rose to -$1.2 million in Q2 2026, from -$4.2 million in the prior quarter.
• Across five years, EBITDA topped out at $5.8 million in Q2 2022 and bottomed at -$4.6 million in Q4 2025.
• Historically, EBITDA has averaged $650166.7 across 5 years, with a median of $308500.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: EBITDA soared 868.39% in 2022, then tumbled 2657.23% in 2025.
• Over 5 years, EBITDA stood at $3.5 million in 2022, then jumped by 56.9% to $5.5 million in 2023, then slumped by 127.67% to -$1.5 million in 2024, then tumbled by 207.2% to -$4.6 million in 2025, then soared by 74.05% to -$1.2 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$1.2 million, -$4.2 million, and -$4.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.